These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1301665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Utilization of serological methods in the retrospective diagnosis of cholera and in detecting vibrion carriers].
    Bunin KV, Firsanov VI, Kravtsov EG, Nechaeva IP, Efimov DD.
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):98-101. PubMed ID: 1210898
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
    Bendib A, Bougoudogo F, Messast M, Rezkallah D, Hamchi L, Bellouche Y, Aidoud NS, Keddouri A, Fournier JM, Dodin A.
    Bull Soc Pathol Exot; 1994 Oct; 87(1):33-7. PubMed ID: 8003902
    [Abstract] [Full Text] [Related]

  • 6. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML, Levine MM, Young CR, Black RE, Lim YL, Robins-Browne RM, Craig JP.
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
    Takeda T, Ramamurthy T, Chowdhury AS, Dutta D, Bhattacharya SK, Deb BC, Nair GB, Takeda Y.
    J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
    [No Abstract] [Full Text] [Related]

  • 11. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS, An SJ, Jang MS, Song M, Han SH.
    PLoS One; 2019 Sep; 14(3):e0213507. PubMed ID: 30845262
    [Abstract] [Full Text] [Related]

  • 12. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D, LaRocque RC, Khan AI, Harris JB, Begum YA, Akramuzzaman SM, Faruque AS, Ryan ET, Qadri F, Calderwood SB.
    J Infect Dis; 2004 Jun 15; 189(12):2318-22. PubMed ID: 15181581
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Determination of bactericidal antibodies directed against vibrio cholerae in an adult population in Montevideo].
    Varela G, Del'Acqua L, Hortal M.
    Rev Argent Microbiol; 1995 Jun 15; 27(4):185-90. PubMed ID: 8850130
    [Abstract] [Full Text] [Related]

  • 15. [Detection of convalescent Vibrio cholerae carriers using the enterotest].
    Grados P, Battilana C.
    Bol Oficina Sanit Panam; 1994 Apr 15; 116(4):285-9. PubMed ID: 8037848
    [Abstract] [Full Text] [Related]

  • 16. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU, Barua DK, Begum T, Shahidullah M.
    Trop Geogr Med; 1987 Jul 15; 39(3):271-5. PubMed ID: 3433343
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS, Losonsky GA, Noriega F, Tacket CO, Castañeda E, Levine MM.
    Vaccine; 1994 Aug 15; 12(11):1000-3. PubMed ID: 7975839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
    Taylor DN, Cárdenas V, Perez J, Puga R, Svennerholm AM.
    Am J Trop Med Hyg; 1999 Dec 15; 61(6):869-73. PubMed ID: 10674661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.